Literature DB >> 26414111

The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders.

Luca Antonioli1, Rocchina Colucci1, Carolina Pellegrini1, Giulio Giustarini1, Deborah Sacco1, Erika Tirotta1, Valentina Caputi2, Ilaria Marsilio2, Maria Cecilia Giron2, Zoltán H Németh3,4, Corrado Blandizzi1, Matteo Fornai1.   

Abstract

INTRODUCTION: Adenosine monophosphate-activated protein kinase (AMPK), known as an enzymatic complex that regulates the energetic metabolism, is emerging as a pivotal enzyme and enzymatic pathway involved in the regulation of immune homeostatic networks. It is also involved in the molecular mechanisms underlying the pathophysiology of chronic inflammatory diseases. AREAS COVERED: AMPK is expressed in several immune cell types including macrophages, lymphocytes, neutrophils and dendritic cells, and governs a broad array of cell functions, which include cytokine production, chemotaxis, cytotoxicity, apoptosis and proliferation. Based on its wide variety of immunoregulatory actions, the AMPK system has been targeted to reveal its impact on the course of immune-related diseases, such as atherosclerosis, psoriasis, joint inflammation and inflammatory bowel diseases. EXPERT OPINION: The identification of AMPK subunits responsible for specific anti-inflammatory actions and the understanding of the underlying molecular mechanisms will promote the generation of novel AMPK activators, endowed with improved pharmacodynamic and pharmacokinetic profiles. These new tools will aid us to utilize AMPK pathway activation in the management of acute and chronic inflammatory diseases, while minimizing potential adverse reactions related to the effects of AMPK on metabolic energy.

Entities:  

Keywords:  adenosine; adenosine monophosphate-activated protein kinase; adenosine triphosphate; dendritic cells; immune system; inflammation; inflammatory disease; lymphocytes; macrophages; neutrophils

Mesh:

Substances:

Year:  2015        PMID: 26414111     DOI: 10.1517/14728222.2016.1086752

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  13 in total

1.  The ecto-enzymes CD73 and adenosine deaminase modulate 5'-AMP-derived adenosine in myofibroblasts of the rat small intestine.

Authors:  Anna Bin; Valentina Caputi; Michela Bistoletti; Monica Montopoli; Rocchina Colucci; Luca Antonioli; Sara De Martin; Ignazio Castagliuolo; Genny Orso; Cristina Giaroni; Patrizia Debetto; Maria Cecilia Giron
Journal:  Purinergic Signal       Date:  2018-09-29       Impact factor: 3.765

2.  Broccoli-Derived Nanoparticle Inhibits Mouse Colitis by Activating Dendritic Cell AMP-Activated Protein Kinase.

Authors:  Zhongbin Deng; Yuan Rong; Yun Teng; Jingyao Mu; Xiaoying Zhuang; Michael Tseng; Abhilash Samykutty; Lifeng Zhang; Jun Yan; Donald Miller; Jill Suttles; Huang-Ge Zhang
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

Review 3.  Focusing on Future Applications and Current Challenges of Plant Derived Extracellular Vesicles.

Authors:  Yuchen Wang; Junfeng Wang; Jinqian Ma; Yun Zhou; Rong Lu
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-03

Review 4.  Protective benefits of AMP-activated protein kinase in hepatic ischemia-reperfusion injury.

Authors:  Min Zhang; Dan Yang; Xianqiong Gong; Pu Ge; Jie Dai; Ling Lin; Li Zhang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

5.  The roles of AMPK-mediated autophagy and mitochondrial autophagy in a mouse model of imiquimod-induced psoriasis.

Authors:  Hui Shen; Yan Sha; Jun Huang; An-Qi Mao; Tao Zhang; Mu-Yao Wu; Fang Sun; Ying-Yuan Yu; Zhong-Qin Cheng; Ya-Ting Gong
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

6.  Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.

Authors:  Luca Antonioli; Carolina Pellegrini; Matteo Fornai; Laura Benvenuti; Vanessa D'Antongiovanni; Rocchina Colucci; Lorenzo Bertani; Clelia Di Salvo; Giorgia Semeghini; Concettina La Motta; Laura Giusti; Lorenzo Zallocco; Maurizio Ronci; Luca Quattrini; Francesco Angelucci; Vito Coviello; Won-Keun Oh; Quy Thi Kim Ha; Zoltan H Németh; Gyorgy Haskó; Corrado Blandizzi
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

7.  The Effects of Berberine on Concanavalin A-Induced Autoimmune Hepatitis (AIH) in Mice and the Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase (AMPK) Pathway.

Authors:  Yangyang Wang; Lu Zhou; Yanni Li; Liping Guo; Zhe Zhou; Haoran Xie; Yingjian Hou; Bangmao Wang
Journal:  Med Sci Monit       Date:  2017-12-28

Review 8.  Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence.

Authors:  Arduino A Mangoni; Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Matteo Piga; Gian Luca Erre
Journal:  Mediators Inflamm       Date:  2017-12-21       Impact factor: 4.711

Review 9.  The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.

Authors:  Margarete Dulce Bagatini; Alessandra Antunes Dos Santos; Andréia Machado Cardoso; Aline Mânica; Cristina Ruedell Reschke; Fabiano Barbosa Carvalho
Journal:  J Immunol Res       Date:  2018-08-12       Impact factor: 4.818

10.  Lipopolysaccharide-Induced Dephosphorylation of AMPK-Activated Protein Kinase Potentiates Inflammatory Injury via Repression of ULK1-Dependent Autophagy.

Authors:  Kerui Fan; Ling Lin; Qing Ai; Jingyuan Wan; Jie Dai; Gang Liu; Li Tang; Yongqiang Yang; Pu Ge; Rong Jiang; Li Zhang
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.